Clinical Trial Update: Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary [NA]

View source ↗

Summary

Clinical trial registry entry for meclofenamate in recurrent or progressive brain metastases from solid tumors; trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Meclofenamate (Meclofenamate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Recurrent Brain Metastases, Progressive Brain Metastases | NA | Status: ACTIVE_NOT_RECRUITING